Vitrafy Life Sciences Partners With Vitalant Innovation Center on Red Blood Cell Preservation Technology

MT Newswires Live

06/02

Vitrafy Life Sciences (ASX:VFY) has partnered with US healthcare organization Vitalant Innovation Center to address a "looming crisis" for red blood cell preservation, according to a Tuesday filing with the Australian bourse.

The companies aim to configure Vitrafy's cryopreservation ecosystem as a successor to legacy technology and products that will be discontinued from 2027, which poses a threat to red blood cell stockpiles, per the filing.

To support that objective, Vitrafy will initially place two cryopreservation freezing units at the Vitalant Innovation Center in Denver. The placement will not generate revenue, but the company expects the collaboration "to support broader market and government engagement toward a unified response," it said.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2640551995"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2640551995\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2640551995?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-02 09:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2640551995","market":"fut","top_or_hot":-1,"title":"Vitrafy Life Sciences Partners With Vitalant Innovation Center on Red Blood Cell Preservation Technology","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/VFY.AU\">Vitrafy Life</a> Sciences (ASX:VFY) has partnered with US healthcare organization Vitalant Innovation Center to address a \"looming crisis\" for red blood cell preservation, according to a Tuesday filing with the Australian bourse.</p><p>The companies aim to configure Vitrafy's cryopreservation ecosystem as a successor to legacy technology and products that will be discontinued from 2027, which poses a threat to red blood cell stockpiles, per the filing.</p><p>To support that objective, Vitrafy will initially place two cryopreservation freezing units at the Vitalant Innovation Center in Denver. The placement will not generate revenue, but the company expects the collaboration \"to support broader market and government engagement toward a unified response,\" it said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vitrafy Life Sciences Partners With Vitalant Innovation Center on Red Blood Cell Preservation Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVitrafy Life Sciences Partners With Vitalant Innovation Center on Red Blood Cell Preservation Technology\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-06-02 09:12</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/VFY.AU\">Vitrafy Life</a> Sciences (ASX:VFY) has partnered with US healthcare organization Vitalant Innovation Center to address a \"looming crisis\" for red blood cell preservation, according to a Tuesday filing with the Australian bourse.</p><p>The companies aim to configure Vitrafy's cryopreservation ecosystem as a successor to legacy technology and products that will be discontinued from 2027, which poses a threat to red blood cell stockpiles, per the filing.</p><p>To support that objective, Vitrafy will initially place two cryopreservation freezing units at the Vitalant Innovation Center in Denver. The placement will not generate revenue, but the company expects the collaboration \"to support broader market and government engagement toward a unified response,\" it said.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VFY.AU","symbol_name":"Vitrafy Life Sciences Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2640551995","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2640551995","pubTimestamp":1780362756,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Vitrafy Life Sciences  has partnered with US healthcare organization Vitalant Innovation Center to address a \"looming crisis\" for red blood cell preservation, according to a Tuesday filing with the Australian bourse.The companies aim to configure Vitrafy's cryopreservation ecosystem as a successor to legacy technology and products that will be discontinued from 2027, which poses a threat to red blood cell stockpiles, per the filing.To support that objective, Vitrafy will initially place two cryopreservation freezing units at the Vitalant Innovation Center in Denver. The placement will not generate revenue, but the company expects the collaboration \"to support broader market and government engagement toward a unified response,\" it said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VFY.AU":"Vitrafy Life Sciences Ltd","BK7048":"生命科学工具和服务"},"translate_title":"Vitrafy Life Sciences与Vitalant创新中心合作开发红细胞保存技术","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VFY.AU":1},"content_text":"Vitrafy Life Sciences (ASX:VFY) has partnered with US healthcare organization Vitalant Innovation Center to address a \"looming crisis\" for red blood cell preservation, according to a Tuesday filing with the Australian bourse.The companies aim to configure Vitrafy's cryopreservation ecosystem as a successor to legacy technology and products that will be discontinued from 2027, which poses a threat to red blood cell stockpiles, per the filing.To support that objective, Vitrafy will initially place two cryopreservation freezing units at the Vitalant Innovation Center in Denver. The placement will not generate revenue, but the company expects the collaboration \"to support broader market and government engagement toward a unified response,\" it said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}